The Neuraxpharm Group, a leading European pharmaceutical company, has appointed Dirk Greshake as the new Country Manager for Germany, effective July 1, 2024. Neuraxpharm specializes in the treatment of central nervous system (CNS) disorders, including neuraxpharm® Arzneimittel GmbH, based in Langenfeld (Rhineland). With this appointment, the company aims to continue its growth strategy in the significant German market.
Dirk Greshake brings over 25 years of experience in senior positions within the pharmaceutical industry. Most recently, he was responsible as Commercial Director for Austria, Switzerland, and Germany at AOP Health, a European company focused on rare diseases. Prior to that, he served as Country Manager for four years at Zambon Germany and Austria, focusing on CNS and respiratory diseases as well as women's health. Other roles include leadership positions at Mediolanum Biosciences and AstraZeneca Germany, where he served as Managing Director for four years.
